RT Conference Proceedings
T1 EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS.
A1 Redondo-Rodriguez, R.
A1 Godoy-Navarrete, F.
A1 Morales-Garrido, P.
A1 Rojas-Gimenez, M.
A1 Romero-Barco, C. M.
A1 Mena-Vazquez, N.
K1 Abatacept
K1 Retrospective studies
K1 Prospective studies
AB Background: Interstitial Lung Disease (ILD) is the most common lung involvement in rheumatoid arthritis (RA) and leads to increased morbidity and mortality. Some retrospective observational studies suggest that abatacept (ABT) could be effective and safety, although there are no clinical trials and prospectively collected data are scarce. Objectives: To evaluate prospective the effectiveness and safety of ABT in patients with ILD associated RA (ILD-RA).
PB Bmj publishing group
SN 0003-4967
YR 2022
FD 2022-06-01
LK http://hdl.handle.net/10668/20095
UL http://hdl.handle.net/10668/20095
LA en
NO Rodriguez RR, Godoy-Navarrete F, Morales-Garrido P, Rojas-Giménez M, Romero-Barco CM, Mena-Vázquez N. POS0654 EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):599.1-599
DS RISalud
RD Apr 8, 2025